Company / Operating Cash Flow
IQVIA Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$2.7B
FY2025
5-year range
$1.4B / $2.7B
FY2021-FY2025
Trend
-2.3%
vs FY2024
Sector context
#17 of 164
Health Care
What the data says
Among 164 Health Care companies, IQVIA is in the top 10% for operating cash flow. Operating Cash Flow has fluctuated over the past 10 years, ranging from $860M in FY2018 to $2.7B in FY2024.
Based on SEC 10-K filings.
$2.7B in FY2025 with a 5-year CAGR of +16.2%. Top quartile in the Health Care sector.
Improved from $2.1B to $2.7B over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +10.7%
- 5-Year CAGR
- +16.2%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 164This company $2.7B Sector average $1.0B
▼
+154.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +16.2%, indicating consistent growth.
- In FY2025, operating cash flow decreased 2.3% year-over-year.
- Ranks #17 out of 164 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 20.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7B | -2.3% |
| FY2024 | $2.7B | +26.4% |
| FY2023 | $2.1B | +9.7% |
| FY2022 | $2.0B | +38.2% |
| FY2021 | $1.4B | +13.0% |
| FY2020 | $1.3B | +29.3% |
| FY2019 | $970.0M | +12.8% |
| FY2018 | $860.0M | -11.3% |
| FY2017 | $970.0M | +12.8% |
| FY2016 | $860.0M | +80.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026